Skip to main content
OpenTrials

Clinical trial condition

Wet Macular Degeneration

Explore clinical trials studying Wet Macular Degeneration. Study availability and eligibility vary by location and protocol.

40 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Wet Macular Degeneration trial results

Recruiting

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

NCT07440225

Conditions
Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +10 more
Locations
  • Research Network Arizona / Retina Macula Institute of Arizona Scottsdale, Arizona, United States
  • Retina Center of Arkansas Fayetteville, Arkansas, United States
  • Retina Partners of Northwest Arkansas, PLLC Springdale, Arkansas, United States
  • Global Research Management, Inc. Glendale, California, United States
View all 110 locations
View Trial Details
Recruiting

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

NCT07496567

Conditions
Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +10 more
Locations
  • Associated Retina Consultants - Gilbert Gilbert, Arizona, United States
  • The Retina Partners Encino, California, United States
  • Northern California Retina Vitreous Associates Medical Group, Inc. Mountain View, California, United States
  • Retina Consultants of Southern Colorado Colorado Springs, Colorado, United States
View all 71 locations
View Trial Details
Enrolling by invitation

Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy

NCT03999801

Conditions
Eye Diseases, Macular Degeneration, Neovascular Age-related Macular Degeneration, +3 more
Locations
  • Retinal Research Institute, LCC Phoenix, Arizona, United States
  • California Retina Consultants CRC Santa Barbara, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Ophthalmic Consultants of Boston Boston, Massachusetts, United States
View Trial Details
Completed

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

NCT03834753

Conditions
Age-Related Macular Degeneration, Eye Diseases, Macular Degeneration, +4 more
Locations
  • Clinical Site Tucson, Arizona, United States
  • Clinical Site Arcadia, California, United States
  • Clinical Site Beverly Hills, California, United States
  • Clinical Site Campbell, California, United States
View all 50 locations
View Trial Details
Completed

A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

NCT06190093

Conditions
Age-Related Macular Degeneration, Eye Diseases, Macular Degeneration, +4 more
Locations
  • Clinical Site Arcadia, California, United States
  • Clinical Site Bakersfield, California, United States
  • Clinical Site Beverly Hills, California, United States
  • Clinical Site Huntington Beach, California, United States
View all 61 locations
View Trial Details
Completed

A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders

NCT04516278

Conditions
Age-Related Macular Degeneration, BRVO - Branch Retinal Vein Occlusion, Cardiovascular Diseases, +12 more
Locations
  • Clinical Site Tucson, Arizona, United States
  • Clinical Site Beverly Hills, California, United States
  • Clinical Site Glendale, California, United States
  • Clinical Site Long Beach, California, United States
View all 20 locations
View Trial Details
Completed

A Randomized, Double Masked, Parallel Group, Dose-finding Study to Evaluate SYL1801 in Patients With Neovascular Age-related Macular Degeneration (AMD)

NCT05637255

Conditions
Eye Diseases, Macular Degeneration, Neovascular Age-related Macular Degeneration, +3 more
Locations
  • SYL1801 Investigative Site Brno, Czechia
  • SYL1801 Investigative Site Chomutov, Czechia
  • SYL1801 Investigative Site Frýdek-Místek, Czechia
  • SYL1801 Investigative Site Kyjov, Czechia
View all 16 locations
View Trial Details

Related conditions